Mining the Wnt pathway for cancer therapeutics
- PMID: 17139285
- DOI: 10.1038/nrd2154
Mining the Wnt pathway for cancer therapeutics
Erratum in
- Nat Rev Drug Discov. 2007 Mar;6(3):249
Abstract
Aberrant activation of the Wnt pathway is implicated in driving the formation of various human cancers, particularly those of the digestive tract. Inhibition of aberrant Wnt pathway activity in cancer cell lines efficiently blocks their growth, highlighting the great potential of therapeutics designed to achieve this in cancer patients. Here we provide an overview of the promise and pitfalls of current drug development strategies striving to inhibit the Wnt pathway and present new opportunities for therapeutic intervention.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
